Our Recommendations
- Standard operating procedures for supply chain management of health products for neglected tropical diseases amenable to preventive chemotherapy (2022)
- Chronic Care for Neglected Infectious Diseases: Leprosy/ Hansen’s Disease, Lymphatic Filariasis, Trachoma, and Chagas Disease (2021)
- Lymphatic Filariasis and Podoconiosis morbidity management and disability prevention guidelines (2016)
- Bench Aids for the diagnosis of filarial infections (1997)
- Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition (2021)
New Publications
- Operational manual on indoor residual spraying: Control of vectors of malaria, Aedes-borne diseases, Chagas disease, leishmaniases and lymphatic filariasis (2024)
- Practical Approaches to Implementing WHO Guidance for Neglected Tropical Disease (NTD) Programs in the Context of COVID-19: Trachoma Surveys (2021)
- La fin est en vue: De la collaboration à l’élimination (2022)
- The End in sight: from collaboration to elimination (2022)
- Intervention manual for the integrated managment of skin neglected tropcial diseases (2021)
Filter
56
Featured
Recommendations
8
New Publications
1
Language
Document type
Studies & Reports
25
Guidelines
10
Manuals
6
Videos
5
Infographics
3
Strategic & Response Plan
3
Training Material
2
App
1
Fact sheets
1
Countries / Regions
Global
18
Africa
2
Nigeria
1
Latin America and the Carribbean
1
Saudi Arabia
1
Western Pacific Region
1
Djibouti
1
Egypt
1
Sudan
1
Yemen
1
Ethiopia
1
Zambia
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Countries
6
Clinical Guidelines
5
Public Health
1
Pharmacy & Technologies
1
Better drug regimens for mass drug administration (MDA) could accelerate the Global Programme to Eliminate Lymphatic Filariasis (LF). This community study was designed to compare the safety and efficacy of MDA with IDA (ivermectin, diethylcarbamazine and albendazole) or DA (diethylcarbamazine and ...
Lymphatic filariasis (LF), a neglected tropical disease, is targeted for global elimination as a public health problem. This article reviews the history of LF control and elimination activities in the countries of the World Health Organization's (WHO) Eastern Mediterranean Region (EMR) over the last...
Lymphatic filariasis (LF) is a preventable neglected tropical disease (NTD) caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi or B. timori. Mosquitos in the genera Culex, Anopheles, Mansonia and Aedes transmit the parasites from person to person. Lymphoedema and hyd...
Since the launch of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000, more than 910 million people have received preventive chemotherapy for lymphatic filariasis (LF) and many thousands have received care for chronic manifestations of the disease. To achieve this, millions of c...
To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Afric...
This manual details a collaboratively developed intervention to detect and refer Buruli ulcer, Hydrocele, Leprosy
and Lymphedema cases through the use of integrated approaches at community levels. This intervention has
been developed as part of the consortium in partnership with the Nigerian Feder...
Version 1: March 9, 2021. A living document
In South and Central America, lymphatic filariasis (LF) is caused by Wuchereria bancrofti, which is transmitted by Culex quinquefasciatus, the only vector species in this region. Of the seven countries considered endemic for LF in the Americas in the last decade, Costa Rica, Suriname and Trinidad a...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
Dickson and Daniel discuss lymphatic filariasis caused by the helminths Wuchereria bancrofti and Brugia malayai.
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
Lymphatic Filariasis and Podoconiosis morbidity management and disability prevention guidelines
recommended
National Guideline
This video is part of a comprehensive medical school microbiology, immunology & infectious diseases course. Your comments on videos will be key as we iterate content.
Monitoramento efetivo, avaliação epidemiológica e análise subsequente são
necessários para atingir o objetivo de interromper a transmissão da FL. Este manual foi
elaborado para oferecer aos programas nacionais de eliminação da fi lariose informação de qualidade sobre metodologias e proc...
